These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15878404)

  • 1. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains.
    van der Aa Kühle A; Skovgaard K; Jespersen L
    Int J Food Microbiol; 2005 May; 101(1):29-39. PubMed ID: 15878404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
    Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
    Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assimilation of cholesterol by yeast strains isolated from infant feces and Feta cheese.
    Psomas EI; Fletouris DJ; Litopoulou-Tzanetaki E; Tzanetakis N
    J Dairy Sci; 2003 Nov; 86(11):3416-22. PubMed ID: 14672170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of calcium ions on adhesion and competitive exclusion of Lactobacillus ssp. and E. coli O138.
    Larsen N; Nissen P; Willats WG
    Int J Food Microbiol; 2007 Feb; 114(1):113-9. PubMed ID: 17234293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii.
    Fietto JL; Araújo RS; Valadão FN; Fietto LG; Brandão RL; Neves MJ; Gomes FC; Nicoli JR; Castro IM
    Can J Microbiol; 2004 Aug; 50(8):615-21. PubMed ID: 15467787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of Saccharomyces cerevisiae strains from different food matrices and their preliminary selection for a potential use as probiotics.
    Pennacchia C; Blaiotta G; Pepe O; Villani F
    J Appl Microbiol; 2008 Dec; 105(6):1919-28. PubMed ID: 19120638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections.
    de Llanos R; Querol A; Pemán J; Gobernado M; Fernández-Espinar MT
    Int J Food Microbiol; 2006 Aug; 110(3):286-90. PubMed ID: 16782223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pH, bile and calcium on the adhesion ability of probiotic enterococci of animal origin to the porcine jejunal epithelial cell line IPEC-J2.
    Marcináková M; Klingberg TD; Lauková A; Budde BB
    Anaerobe; 2010 Apr; 16(2):120-4. PubMed ID: 19446648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.
    Capece A; Romaniello R; Pietrafesa A; Siesto G; Pietrafesa R; Zambuto M; Romano P
    Int J Food Microbiol; 2018 Nov; 284():22-30. PubMed ID: 29990636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtractive screening for probiotic properties of lactobacillus species from the human gastrointestinal tract in the search for new probiotics.
    Delgado S; O'Sullivan E; Fitzgerald G; Mayo B
    J Food Sci; 2007 Oct; 72(8):M310-5. PubMed ID: 17995611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Saccharomyces cerevisiae var. boulardii in food processing: a review.
    Lazo-Vélez MA; Serna-Saldívar SO; Rosales-Medina MF; Tinoco-Alvear M; Briones-García M
    J Appl Microbiol; 2018 Oct; 125(4):943-951. PubMed ID: 29961970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Datta S; Timson DJ; Annapure US
    J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors.
    de Llanos R; Fernández-Espinar MT; Querol A
    Antonie Van Leeuwenhoek; 2006 Oct; 90(3):221-31. PubMed ID: 16871421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: yeast as probiotics -- Saccharomyces boulardii.
    Czerucka D; Piche T; Rampal P
    Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine intestinal epithelial cell lines as a new in vitro model for studying adherence and pathogenesis of enterotoxigenic Escherichia coli.
    Koh SY; George S; Brözel V; Moxley R; Francis D; Kaushik RS
    Vet Microbiol; 2008 Jul; 130(1-2):191-7. PubMed ID: 18261863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge.
    Lessard M; Dupuis M; Gagnon N; Nadeau E; Matte JJ; Goulet J; Fairbrother JM
    J Anim Sci; 2009 Mar; 87(3):922-34. PubMed ID: 19028865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saccharomyces cerevisiae decreases inflammatory responses induced by F4+ enterotoxigenic Escherichia coli in porcine intestinal epithelial cells.
    Zanello G; Meurens F; Berri M; Chevaleyre C; Melo S; Auclair E; Salmon H
    Vet Immunol Immunopathol; 2011 May; 141(1-2):133-8. PubMed ID: 21354630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cells.
    Badia R; Brufau MT; Guerrero-Zamora AM; Lizardo R; Dobrescu I; Martin-Venegas R; Ferrer R; Salmon H; Martínez P; Brufau J
    Clin Vaccine Immunol; 2012 Mar; 19(3):368-76. PubMed ID: 22301691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407.
    Murzyn A; Krasowska A; Augustyniak D; Majkowska-Skrobek G; Łukaszewicz M; Dziadkowiec D
    FEMS Microbiol Lett; 2010 Sep; 310(1):17-23. PubMed ID: 20629753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro investigation of Debaryomyces hansenii strains for potential probiotic properties.
    Ochangco HS; Gamero A; Smith IM; Christensen JE; Jespersen L; Arneborg N
    World J Microbiol Biotechnol; 2016 Sep; 32(9):141. PubMed ID: 27430508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.